FiLeClo is a technology company that operates in the pharmaceutical industry, focusing on the development and commercialization of research projects related to cancer treatment. Its primary product is the therapeutic substance FLC-436, which has anti-proliferative effects on various cancer cell lines. FiLeClo targets pharmaceutical companies and aims to expand its capabilities in medical chemistry.
Headquarters
Ul. Al. Marsz. Jozefa Pilsudskiego 141
Lodz; Lodzkie;
Postal Code: 92-318
Contact Details: Purchase the Fileclo Sp. z o.o. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service